Skip to main content

Table 2 Prevalence of pHR/HR and low risk HPV infection and other sexually transmitted infections

From: Distribution of human papillomaviruses and bacterial vaginosis in HIV positive women with abnormal cytology in Mombasa, Kenya

Type of infection N Percentage (95 % CI)
HR HPV:
 HPV 16 25 33.8 % (22.8–44.8)
 HPV 18 13 17.6 % (8.7–26.4)
 HPV 31 11 14.9 % (6.6–23.2)
 HPV 33 12 16.2 % (7.6–24.8)
 HPV 35 13 17.6 % (8.7–26.4)
 HPV 45 3 4.1 % (0.5–8.7)
 HPV 39 8 10.8 % (3.6–18.1)
 HPV 51 11 14.9 % (6.6–23.2)
 HPV 52 15 20.3 % (10.9–29.6)
 HPV 53 18 24.3 % (14.3–34.4)
 HPV 56 15 20.3 % (10.9–29.6)
 HPV 58 13 17.6 % (8.7–26.4)
 HPV 66 11 14.9 % (6.6–23.2)
 HPV 68 4 5.4 % (0.1–10.7)
 Multiple HR HPV 48 64.9 % (53.7–76.0)
 Women on HAART 60 82.0 (80.0–90.2)
LR HPV:
 HPV 6 4 5.4 % (4.4–6.4)
 HPV 67 0 0
 No HPV infection: 6 8.1 % (3.0–16.8)
STIs:
 BV 46 62.2 % (50.9–73.5)
 Genital ulcer 12 16.2 % (7.6–24.8)
 Genital warts 8 10.8 % (3.6–18.1)
 Trichomonas vaginalis 1 1.4 % (0.1–4.0)
 Cervicitis 11 14.9 % (6.6–23.2)
 STI prevalence 51 68.9 % (58.1–79.7)
 More than one STI 8 10.7 % (3.5–17.8)